Bahl & Gaynor Inc Phibro Animal Health Corp Transaction History

Bahl & Gaynor Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$21.0 - $24.83 $965,580 - $1.14 Million	-45,980 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$20.34 - $32.66 $305 - $489	15 Added 0.03%	45,980 $980,000
Q2 2019 Aug 12, 2019	SELL	$28.03 - $36.85 $1.07 Million - $1.41 Million	-38,182 Reduced 45.38%	45,965 $1.46 Million
Q1 2019 May 13, 2019	BUY	$28.71 - $33.65 $67,267 - $78,841	2,343 Added 2.86%	84,147 $2.78 Million
Q4 2018 Feb 12, 2019	BUY	$31.18 - $44.64 $82,502 - $118,117	2,646 Added 3.34%	81,804 $2.63 Million
Q3 2018 Nov 09, 2018	BUY	$42.3 - $53.5 $902,428 - $1.14 Million	21,334 Added 36.89%	79,158 $3.4 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $48.1 $2.24 Million - $2.78 Million	57,824 New	57,824 $2.66 Million

148

20.4M

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $440M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.